Metabolic response to epigallocatechin-3-gallate in relapsing-remitting multiple sclerosis: A randomized clinical trial

American Journal of Clinical Nutrition

Volumn 101, Issue 3, 2015, Pages 487-495

  Mähler, Anja ^a   Steiniger, Jochen ^a   Bock, Markus ^a   Klug, Lars ^a   Parreidt, Nadine ^a   Lorenz, Mario ^a,b   Zimmermann, Benno F ^c,d   Krannich, Alexander ^e   Paul, Friedemann ^a   Boschmann, Michael ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^c UNIVERSITY OF BONN   (Germany)

^d Institut Prof Dr Georg Kurz GmbH   (Germany)

^e BERLIN INSTITUTE OF HEALTH   (Germany)

Author keywords

Calorimetry; Energy metabolism; Epigallocatechin 3 gallate; Microdialysis; Multiple sclerosis; Sex difference

Indexed keywords

CARBOHYDRATE; EPIGALLOCATECHIN GALLATE; FAT; GLATIRAMER; GLUCOSE; PLACEBO; CATECHIN; IMMUNOSUPPRESSIVE AGENT; NEUROPROTECTIVE AGENT; PEPTIDE;

ADIPOSE TISSUE; ADULT; ARTICLE; ASSESSMENT OF HUMANS; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL RESEARCH; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET RESTRICTION; DOUBLE BLIND PROCEDURE; ENERGY EXPENDITURE; ENERGY METABOLISM; EXERCISE; EXPANDED DISABILITY STATUS SCALE SCORE; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; OXIDATION; POSTPRANDIAL STATE; RANDOMIZED CONTROLLED TRIAL; REST; SKELETAL MUSCLE; TISSUE PERFUSION; ABDOMINAL SUBCUTANEOUS FAT; ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; CARBOHYDRATE METABOLISM; CLINICAL TRIAL; COMPARATIVE STUDY; DIET SUPPLEMENTATION; DIET THERAPY; DRUG EFFECTS; LIPID METABOLISM; METABOLISM; MIDDLE AGED; MOTOR ACTIVITY; MULTIMODALITY CANCER THERAPY; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PATHOPHYSIOLOGY; SEVERITY OF ILLNESS INDEX; SEXUAL DEVELOPMENT;

ADULT; CARBOHYDRATE METABOLISM; CATECHIN; COMBINED MODALITY THERAPY; CROSS-OVER STUDIES; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; ENERGY METABOLISM; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIPID METABOLISM; MALE; MIDDLE AGED; MOTOR ACTIVITY; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; MUSCLE, SKELETAL; NEUROPROTECTIVE AGENTS; PEPTIDES; POSTPRANDIAL PERIOD; SEVERITY OF ILLNESS INDEX; SEX CHARACTERISTICS; SUBCUTANEOUS FAT, ABDOMINAL;

EID: 84928430504     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.113.075309     Document Type: Article

References (50)

1. Sinnecker T, Mittelstaedt P, Dorr J, Pfueller CF, Harms L, Niendorf T, Paul F, Wuerfel J. Multiple sclerosis lesions and irreversible brain tissue damage: a comparative ultrahigh-field strength magnetic resonance imaging study. Arch Neurol 2012;69:739-45.
2. Compston A, Coles A. Multiple sclerosis. Lancet 2008;372:1502-17.
3. Brandt AU, Oberwahrenbrock T, Ringelstein M, Young KL, Tiede M, Hartung HP, Martin R, Aktas O, Paul F, Schippling S. Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography. Brain 2011;134:e193.
4. Stadelmann C, Wegner C, Bruck W. Inflammation, demyelination, and degeneration-recent insights from MS pathology. Biochim Biophys Acta 2011;1812:275-82.
5. Andreasen AK, Jakobsen J, Petersen T, Andersen H. Fatigued patients with multiple sclerosis have impaired central muscle activation. Mult Scler 2009;15:818-27.
6. Weinges-Evers N, Brandt AU, Bock M, Pfueller CF, Dorr J, Bellmann-Strobl J, Scherer P, Urbanek C, Boers C, Ohlraun S, et al. Correlation of self-assessed fatigue and alertness in multiple sclerosis. Mult Scler 2010;16:1134-40.
7. Mähler A, Mandel S, Lorenz M, Ruegg U, Wanker EE, Boschmann M, Paul F. Epigallocatechin-3-gallate: a useful, effective and safe clinical approach for targeted prevention and individualised treatment of neurological diseases? EPMA J 2013;4:5.
8. Aktas O, Prozorovski T, Smorodchenko A, Savaskan NE, Lauster R, Kloetzel PM, Infante-Duarte C, Brocke S, Zipp F. Green tea epigallocatechin- 3-gallate mediates T cellular NF-kappa B inhibition and exerts neuroprotection in autoimmune encephalomyelitis. J Immunol 2004;173:5794-800.
9. Herges K, Millward JM, Hentschel N, Infante-Duarte C, Aktas O, Zipp F. Neuroprotective effect of combination therapy of glatiramer acetate and epigallocatechin-3-gallate in neuroinflammation. PLoS ONE 2011; 6:e25456.
10. Wang J, Ren Z, Xu Y, Xiao S, Meydani SN, Wu D. Epigallocatechin-3-gallate ameliorates experimental autoimmune encephalomyelitis by altering balance among CD4+ T-cell subsets. Am J Pathol 2012;180: 221-34.
11. Jeukendrup AE. Regulation of fat metabolism in skeletal muscle. Ann N Y Acad Sci 2002;967:217-35.
12. Mähler A, Steiniger J, Bock M, Brandt AU, Haas V, Boschmann M, Paul F. Is metabolic flexibility altered in multiple sclerosis patients? PLoS ONE 2012;7:e43675.
13. Hodgson AB, Randell RK, Jeukendrup AE. The effect of green tea extract on fat oxidation at rest and during exercise: evidence of efficacy and proposed mechanisms. Adv Nutr 2013;4:129-40.
14. Hodgson AB, Randell RK, Boon N, Garczarek U, Mela DJ, Jeukendrup AE, Jacobs DM. Metabolic response to green tea extract during rest and moderate-intensity exercise. J Nutr Biochem 2013;24:325-34.
15. Witte ME, Geurts JJ, de Vries HE, van der Valk P, van Horssen J. Mitochondrial dysfunction: a potential link between neuroinflammation and neurodegeneration? Mitochondrion 2010;10:411-8.
16. Zhu BH, Chen HY, Zhan WH, Wang CY, Cai SR, Wang Z, Zhang CH, He YL. (-)-Epigallocatechin-3-gallate inhibits VEGF expression induced by IL-6 via Stat3 in gastric cancer. World J Gastroenterol 2011; 17:2315-25.
17. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, Lublin FD, Metz LM, McFarland HF, O'Connor PW, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria." Ann Neurol 2005;58:840-6.
18. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-52.
19. Zimmermann BF, Gleichenhagen M. The effect of ascorbic acid, citric acid and low pH on the extraction of green tea: how to get most out of it. Food Chem 2010;124:1543-8.
20. Ferrannini E. The theoretical bases of indirect calorimetry: a review. Metabolism 1988;37:287-301.
21. Hartshorn JE, Lamb KL. The reproducibility of perceptually regulated exercise responses during short-term cycle ergometry. Int J Sports Med 2004;25:362-7.
22. Zimmermann BF, Papagiannopoulos M, Brachmann S, Lorenz M, Stangl V, Galensa R. A shortcut from plasma to chromatographic analysis: straightforward and fast sample preparation for analysis of green tea catechins in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci 2009;877:823-6.
23. Felländer G, Linde B, Bolinder J. Evaluation of the microdialysis ethanol technique for monitoring of subcutaneous adipose tissue blood flow in humans. Int J Obes Relat Metab Disord 1996;20:220-6.
24. Ståhle L, Segersvard S, Ungerstedt U. A comparison between three methods for estimation of extracellular concentrations of exogenous and endogenous compounds by microdialysis. J Pharmacol Methods 1991;25:41-52.
25. Thielecke F, Rahn G, Bohnke J, Adams F, Birkenfeld AL, Jordan J, Boschmann M. Epigallocatechin-3-gallate and postprandial fat oxidation in overweight/obese male volunteers: a pilot study. Eur J Clin Nutr 2010;64:704-13.
26. Wolfram S, Raederstorff D, Wang Y, Teixeira SR, Elste V, Weber P. TEAVIGO (epigallocatechin gallate) supplementation prevents obesity in rodents by reducing adipose tissue mass. Ann Nutr Metab 2005;49: 54-63.
27. Klaus S, Pultz S, Thone-Reineke C, Wolfram S. Epigallocatechin gallate attenuates diet-induced obesity in mice by decreasing energy absorption and increasing fat oxidation. Int J Obes (Lond) 2005;29: 615-23.
28. Unno T, Tago M, Suzuki Y, Nozawa A, Sagesaka YM, Kakuda T, Egawa K, Kondo K. Effect of tea catechins on postprandial plasma lipid responses in human subjects. Br J Nutr 2005;93:543-7.
29. Wens I, Dalgas U, Stenager E, Eijnde BO. Risk factors related to cardiovascular diseases and the metabolic syndrome in multiple sclerosis-a systematic review. Mult Scler 2013;19:1556-64.
30. Zhu BT, Shim JY, Nagai M, Bai HW. Molecular modelling study of the mechanism of high-potency inhibition of human catechol-Omethyltransferase by (-)-epigallocatechin-3-O-gallate. Xenobiotica 2008;38:130-46.
31. Lorenz M, Paul F, Moobed M, Baumann G, Zimmermann BF, Stangl K, Stangl V. The activity of catechol-O-methyltransferase (COMT) is not impaired by high doses of epigallocatechin-3-gallate (EGCG) in vivo. Eur J Pharmacol 2014;740:645-51.
32. Bérubé-Parent S, Pelletier C, Dore J, Tremblay A. Effects of encapsulated green tea and Guarana extracts containing a mixture of epigallocatechin-3-gallate and caffeine on 24 h energy expenditure and fat oxidation in men. Br J Nutr 2005;94:432-6.
33. Komatsu T, Nakamori M, Komatsu K, Hosoda K, Okamura M, Toyama K, Ishikura Y, Sakai T, Kunii D, Yamamoto S. Oolong tea increases energy metabolism in Japanese females. J Med Invest 2003;50:170-5.
34. Rumpler W, Seale J, Clevidence B, Judd J, Wiley E, Yamamoto S, Komatsu T, Sawaki T, Ishikura Y, Hosoda K. Oolong tea increases metabolic rate and fat oxidation in men. J Nutr 2001;131: 2848-52.
35. Dulloo AG, Duret C, Rohrer D, Girardier L, Mensi N, Fathi M, Chantre P, Vandermander J. Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans. Am J Clin Nutr 1999;70:1040-5.
36. Boschmann M, Thielecke F. The effects of epigallocatechin-3-gallate on thermogenesis and fat oxidation in obese men: a pilot study. J Am Coll Nutr 2007;26:389S-95S.
37. Boschmann M, Steiniger J, Hille U, Tank J, Adams F, Sharma AM, Klaus S, Luft FC, Jordan J. Water-induced thermogenesis. J Clin Endocrinol Metab 2003;88:6015-9.
38. Tappy L. Thermic effect of food and sympathetic nervous system activity in humans. Reprod Nutr Dev 1996;36:391-7.
39. Boschmann M, Steiniger J, Franke G, Birkenfeld AL, Luft FC, Jordan J. Water drinking induces thermogenesis through osmosensitive mechanisms. J Clin Endocrinol Metab 2007;92:3334-7.
40. Rodriguez SK, Guo W, Liu L, Band MA, Paulson EK, Meydani M. Green tea catechin, epigallocatechin-3-gallate, inhibits vascular endothelial growth factor angiogenic signaling by disrupting the formation of a receptor complex. Int J Cancer 2006;118:1635-44.
41. Boschmann M, Engeli S, Adams F, Gorzelniak K, Franke G, Klaua S, Kreuzberg U, Luedtke S, Kettritz R, Sharma AM, et al. Adipose tissue metabolism and CD11b expression on monocytes in obese hypertensives. Hypertension 2005;46:130-6.
42. Murase T, Haramizu S, Shimotoyodome A, Nagasawa A, Tokimitsu I. Green tea extract improves endurance capacity and increases muscle lipid oxidation in mice. Am J Physiol Regul Integr Comp Physiol 2005; 288:R708-15.
43. Randell RK, Hodgson AB, Lotito SB, Jacobs DM, Boon N, Mela DJ, Jeukendrup AE. No effect of 1 or 7 d of green tea extract ingestion on fat oxidation during exercise. Med Sci Sports Exerc 2013;45:883-91.
44. Segal KR, Presta E, Gutin B. Thermic effect of food during graded exercise in normal weight and obese men. Am J Clin Nutr 1984;40: 995-1000.
45. Henry CJ, Lightowler HJ, Marchini J. Intra-individual variation in resting metabolic rate during the menstrual cycle. Br J Nutr 2003;89: 811-7.
46. Horton TJ, Miller EK, Glueck D, Tench K. No effect of menstrual cycle phase on glucose kinetics and fuel oxidation during moderate-intensity exercise. Am J Physiol Endocrinol Metab 2002;282: E752-62.
47. Tai MM, Castillo TP, Pi-Sunyer FX. Thermic effect of food during each phase of the menstrual cycle. Am J Clin Nutr 1997;66:1110-5.
48. Melanson KJ, Saltzman E, Russell R, Roberts SB. Postabsorptive and postprandial energy expenditure and substrate oxidation do not change during the menstrual cycle in young women. J Nutr 1996;126:2531-8.
49. Bisdee JT, James WP, Shaw MA. Changes in energy expenditure during the menstrual cycle. Br J Nutr 1989;61:187-99.
50. Webb P. 24-Hour energy expenditure and the menstrual cycle. Am J Clin Nutr 1986;44:614-9.